Longing for Carefree Days: Grateful After Breast Cancer

I was diagnosed with breast cancer in June 2015. I share my learning that jolted me back on track to a new life. This is my fifth posting. The sun was shining non-stop during July and August in Stockholm. Facebook was filled with pictures of the perfect holiday. As the initial feeling of shock was calming down, I started to long for carefree days. Carefree days. What a wonderful taste these two words have. Carefreeness is a state of mind, but I longed to be carefree on the savanna in Kenya. I have travelled to many wonderful places in the world, but nothing beats waking up in the Masai Mara as the sun rises, putting on a fleece sweater in the chilly tent and drive slowly into the wilderness. Watching a herd of elephants elegantly swaying across the savanna, spending a lazy hour taking photos of a cheetah preparing for a hunt, seeing the curious zebra or hearing the lion roar -- that is pure bliss. I used all my energy to make a trip to Kenya happen. I had to travel within the next days in order to be back for the scheduled radiation therapy. The flight to Nairobi would allow me to go straight to the domestic airport. I could arrive in Masai Mara the same day. I felt elated. I was doing this. I would escape from the cancer summer. But then the noise of scattering glass came from my hallway. My framed zebra photo had literally jumped from the wall and landed on the stone floor. The small photo of an emu antelope was hanging on a corner of its frame. I laughed out load; cl...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

Conclusion: These findings suggest that a pro-inflammatory diet is a risk factor for prostate cancer and also can have the impact on body composition.
Source: Current Nutrition and Food Science - Category: Nutrition Source Type: research
Conclusion: Taken together, AFPE that acts at a low micromolar range against breast cancer cells may be considered as a promising candidate for anticancer therapy.
Source: Current Nutrition and Food Science - Category: Nutrition Source Type: research
Since Invitae’s inception a decade ago, the firm has been working for the proactive use of genetic information in mainstream medicine. The San Francisco, CA-based company has been using M&A activity to help bring companies under its tent to help make this goal a reality. On Monday, the genetic-testing specialist made more progress on this front by announcing it would put down $50 million to acquire Clear Genetics, a company that develops digital counseling software. San Francisco, CA-based Clear Genetics has developed Gia, a chatbot that equips patients with actionable information throughout the genetic t...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Software Source Type: news
No abstract available
Source: Biomedical Safety and Standards - Category: Medical Devices Tags: RECALLS & FIELD CORRECTIONS—CLASS II Source Type: research
John Davies' blood cells will be genetically modified in a US lab in the hope of curing him.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
Abstract Myeloid-derived suppressor cells (MDSCs) have emerged as a new immune regulator at the feto-maternal interface. Although the phenotypes and functions of these cells were primarily studied in pathological conditions such as cancers and infections, new evidence has underscored their beneficial roles in homeostasis and physiological circumstances such as normal pregnancy. In this regard, studies have shown an increased number of MDSCs, particularly granulocytic MDSCs, at the feto-maternal interface. These cells participate in maintaining immunological tolerance between mother and semi-allograft fetus through...
Source: Cellular Immunology - Category: Allergy & Immunology Authors: Tags: Cell Immunol Source Type: research
Publication date: Available online 10 November 2019Source: Seminars in Cancer BiologyAuthor(s): Jessica Burns, Christopher P Wilding, Robin L Jones, Paul H HuangAbstractSarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made over the past few decades. Proteomics techniques are being increasingly utilised in the field of sarcoma research. Proteomic research efforts h...
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Source Type: research
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Source Type: research
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Source Type: research
More News: African Health | Alternative and Complementary Therapies | Anesthesia | Anesthesiology | Anxiety | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Complementary Medicine | Eyes | Health | Hormones | Insomnia | Learning | Men | Menopause | Morphine | Neurology | Radiation Therapy | Sports Medicine | Teachers | Teaching | Tics | Toxicology | Universities & Medical Training | Websites | Women